Achieve Life Sciences Q1 2024 GAAP EPS $(0.26) Misses $(0.24) Estimate
Portfolio Pulse from Benzinga Newsdesk
Achieve Life Sciences reported Q1 2024 GAAP EPS of $(0.26), missing the $(0.24) estimate by 8.33%. This represents a 48% improvement over the $(0.50) per share loss from the same period last year.
May 09, 2024 | 9:10 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Achieve Life Sciences missed Q1 2024 earnings estimates with a $(0.26) EPS, an improvement from last year's $(0.50) loss.
Missing the earnings estimate could negatively impact investor sentiment in the short term, despite the year-over-year improvement in losses. The miss, although slight, may lead to a decrease in stock price as it indicates that the company is not performing as well as expected.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100